NDA 010012

LILLY

FDA Drug Application

Application #010012

Application Sponsors

NDA 010012

LILLY

Marketing Status

• Discontinued: 001

Application Products

001

INJECTABLE;INJECTION

2.5MG/ML

0

SANDRIL

RESERPINE

FDA Submissions

MANUF (CMC); Manufacturing (CMC)	SUPPL	4	AP	1981-10-22	STANDARD
LABELING; Labeling	SUPPL	6	AP	1983-07-20

Submissions Property Types

SUPPL

4

Null

0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 10012
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)